-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

632. Chronic Myeloid Leukemia: Therapy: Poster III Clinically Relevant Abstract

Program: Oral and Poster Abstracts
Type: Poster
Hematology Disease Topics & Pathways:
Adult, Biological, Coronaviruses, Leukemia, SARS-CoV-2/COVID-19, CML, Diseases, CMML, Therapies, Adverse Events, cellular interactions, Biological Processes, immune cells, Technology and Procedures, Cell Lineage, Lymphoid Malignancies, Study Population, Clinically relevant, genomics, Myeloid Malignancies, hematopoiesis, flow cytometry, TKI, molecular testing, stem cells, NGS, pathogenesis
Monday, December 7, 2020: 7:00 AM-3:30 PM

Simone Claudiani1,2*, Carolina Rosadas3*, Myra McClure3*, Maryam Khan3*, Richard S. Tedder3*, Andrew J. Innes1,2*, Dragana Milojkovic1,2* and Jane Apperley, FRCP, FRCPath, MB 1,2

1Centre for Haematology, Faculty of Medicine, Imperial College London, London, United Kingdom
2Department of Haematology, Hammersmith Hospital (Imperial College Healthcare NHS Trust), London, United Kingdom
3St Mary’s Campus, Imperial College London, Faculty of Medicine, London, United Kingdom

Carlo Gambacorti-Passerini, MD1, Alberto Alvarez-Larrán, MD2*, Sarit E Assouline, MD, MSc3, Patrizia Pregno4*, Philipp D le Coutre, MD5, Susanne Saussele, MD6, Laura Antolini, PhD7* and Brian J. Druker, MD8

1Dept of Medicine and Surgery, University of Milano Bicocca, Monza, MB, Italy
2Servicio de Hematologia, Hospital Clinic de Barcelona - GEMFIN, Barcelona, Spain
3Division of Hematology, Sir Mortimer B. Davis-Jewish General Hospital, Department of Oncology, McGill University, Montreal, QC, Canada
4AZ OSP CITTA' DELLA SALUTE E SCIENZA TORINO, University of Torino, TORINO, Italy
5Charité – Universitätsmedizin Berlin, Berlin, Berlin, Germany
6III. Medizinische Klinik, Hämatologie und Onkologie, Universitätsmedizin Mannheim, Mannheim, Germany
7Dept of Medicine and Surgery, University of Milano Bicocca, Monza, Italy
8Knight Cancer Institute, Division of Hematology & Medical Oncology, Oregon Health & Science University, Portland, OR

Veronica A Guerra, MD1, Jorge M. Ramos Perez, MD1*, Danielle Hammond, MD2, Kelly S. Chien, MD1, Rashmi Kanagal-Shamanna, MD3, Kiran Naqvi, MD, MPH2, Koji Sasaki, MD2, Shilpa Paul, PharmD4*, Tapan M. Kadia, MD2, Courtney D. DiNardo, MD, MSc2, Marina Konopleva, MD, PhD2, Naval Daver, MD5, Farhad Ravandi, MBBS2, Naveen Pemmaraju, MD6, Nicholas J. Short, MD2, Ghayas C. Issa, MD2, Koichi Takahashi, MD, PhD2, Zeev E. Estrov, MD1, Sherry A. Pierce, BSN, BA2*, Hagop M. Kantarjian, MD1, Guillermo Garcia-Manero, MD2 and Guillermo Montalban Bravo, MD1

1Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX
2Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
3Department of Hematopathology, University of Texas MD Anderson Cancer Center, Houston, TX
4Department of Pharmacy, The University of Texas MD Anderson Cancer Center, Houston, TX
5The University of Texas MD Anderson Cancer Center, Houston, TX
6University of Texas, MD Anderson Cancer Center, Houston, TX

Jitka Koblihova1*, Vaclava Polivkova2*, Adela Benesova2*, Hana Zizkova2*, Nikola Curik2,3*, Monika Pepek4*, Tomasz Stoklosa, MD, PhD5, Marketa Markova Stastna2*, Hana Klamová2*, Dana Srbova2* and Katerina Machova2,3*

1Institute of Hematology and Blood Transfusion, Prague 2, Czech Republic
2Institute of Hematology and Blood Transfusion, Prague, Czech Republic
3Institute of Pathophysiology, First Faculty of Medicine, Charles University, Prague, Czech Republic
4Medical University of Warsaw, Warsaw, Poland
5Department of Tumor Biology and Genetics, Medical University of Warsaw, Warsaw, Poland

Maria Belen Sanchez1*, Beatriz Moiraghi, MD2*, Ana Ines Varela, MD2*, Estrella Levy, PhD3*, Masiel Vera3*, Bianca Vasconcelos Cordoba3*, Isabel Giere, PhD4*, Josefina Freitas, MD5*, Veronica Ventriglia, MD5*, Maria Del Rosario Custidiano, MD6*, Ana Garcia de Labanca, MD7*, Georgina Bendek, MD8*, Romina Mariano, MD9*, María Jose Mela Osorio, MD4*, Mariana Juni, Ms4*, Maximiliano Riddick10*, Miguel A. Pavlovsky, MD4, Maria Cecilia Foncuberta, MD6, Jose Mordoh, MD3*, Isolda I. Fernandez, MD4*, Julio Cesar Sanchez Avalos, MD6, Carolina Pavlovsky4* and Michele Bianchini, PhD3*

1Centro de Investigaciones Oncológicas CIO-FUCA, Buenos Aires, BA, Argentina
2Hospital General De Agudos J.M. Ramos Mejia, Buenos Aires, Argentina
3Centro de Investigaciones Oncológicas CIO-FUCA, Buenos Aires, Argentina
4FUNDALEU, Buenos Aires, Argentina
5Hospital Posadas, Buenos Aires, Argentina
6Instituto Alexander Fleming, Buenos Aires, Argentina
7-, Mendoza, Argentina
8Hospital Italiano de Buenos Aires, Buenos Aires, Argentina
9Hospital San Martin, Parana, Argentina
10Departamento de Matemática- Facultad de Ciencias Exactas- UNLP, Instituto de Cálculo- Facultad de ciencias exactas y naturales -CONICET, La Plata, Argentina

Koji Sasaki, MD1, Elias Jabbour, MD1, Ghayas C. Issa, MD2, Guillermo Garcia-Manero, MD1, Tapan M. Kadia, MD3, William G. Wierda, MD, PhD1, Musa Yilmaz, MD1, Courtney D. DiNardo, MD, MSc4, Jeffrey Skinner, MHA1*, Maria Khouri1*, Naveen Pemmaraju, MD1, Patrice Nasnas, MD1*, Sherry A. Pierce, BSN, BA1*, Jorge E. Cortes, MD5 and Hagop M. Kantarjian, MD6

1Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
2Department of Leukemia, Universit Y of Texas At Houston, Houston, TX
3Department of Leukemia, M.D. Anderson Cancer Center, Houston, TX
4Department of Leukemia, UT MD Anderson Cancer Center, Houston, TX
5Georgia Cancer Center Augusta University, Augusta, GA
6Department of Leukemia, Professor and Chairman, Department of Leukemia, Samsung Distinguished University Chair in Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX

Guillermo Montalban Bravo, MD1, Rashmi Kanagal-Shamanna, MD2, Veronia Guerra1*, Jorge M. Ramos Perez, MD1*, Danielle Hammond, MD3, Shilpa Paul, PharmD4*, Kiran Naqvi, MD, MPH3, Koji Sasaki, MD3, Elias Jabbour, MD1, Courtney D. DiNardo, MD, MSc3, Koichi Takahashi, MD, PhD1, Marina Konopleva, MD, PhD5, Naveen Pemmaraju, MD6, Tapan M. Kadia, MD3, Farhad Ravandi, MBBS3, Naval Daver, MD7, Gautam Borthakur, MD1, Zeev E. Estrov, MD1, Joseph D. Khoury, MD2, Sanam Loghavi, MD2, Sherry A. Pierce, BSN, BA3*, Carlos E. Bueso-Ramos, MD, PhD2, Keyur Patel, MD, PhD8*, Hagop M. Kantarjian, MD1 and Guillermo Garcia-Manero, MD3

1Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX
2Department of Hematopathology, University of Texas MD Anderson Cancer Center, Houston, TX
3Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
4Department of Pharmacy, The University of Texas MD Anderson Cancer Center, Houston, TX
5Department of Leukemia, University of Texas, MD Anderson Cancer Center, Houston, TX
6University of Texas, MD Anderson Cancer Center, Houston, TX
7The University of Texas MD Anderson Cancer Center, Houston, TX
8University of Texas MD Anderson Cancer Center, Houston, TX

Francois-Xavier Mahon, MD, PhD1, Nelma D Clementino, MD2*, Mikhail Fominykh, MD3,4, Jeffrey H. Lipton, MD, PhD5, Anna G. Turkina, Prof., MD6, Beatriz Moiraghi, MD7*, Franck E Nicolini, MD, PhD8, Naoto Takahashi, MD, PhD9, Tomasz Sacha, MD PhD10*, Dong-Wook Kim, MD11, Rafik Fellague-Chebra, MD12*, Ranjan Tiwari, MSc13*, Catherine Bouard12* and Timothy P. Hughes, MD, MBBS, FRACP, FRCPA14

1Cancer Center of Bordeaux, Institut Bergonié, INSERM U1218, University of Bordeaux, Bordeaux, France
2Hospital Das Clinicas Da UFMG, Belo Horizonte, Brazil
3Russian Research Institute of Hematology and Transfusiology, Saint Petersburg, Russian Federation
4Hematology With BMT, Saint-Petersburg, Russia
5Princess Margaret Cancer Centre, University of Toronto, Toronto, Canada
6National Research Center for Hematology, Moscow, Russian Federation
7Hospital General De Agudos J.M. Ramos Mejia, Buenos Aires, Argentina
8Hematology department, Centre Leon Berard, Lyon, France
9Department of Hematology, Nephrology, and Rheumatology, Akita University Graduate School of Medicine, Akita, Japan
10Department of Hematology, Jagiellonian University Medical College, Krakow, Poland
11Seoul St. Mary's Hospital The Catholic University of Korea, Seoul, Korea, Republic of (South)
12Novartis Pharma SAS, Paris, France
13Novartis Healthcare Pvt. Ltd, Hyderabad, India
14Precision Medicine Theme, South Australian Health and Medical Research Institute, Adelaide, SA, Australia

Anna Petrova, MD1*, Ekaterina Yu. Chelysheva, MD, PhD1*, Oleg A. Shukhov, MD, PhD1*, Anastasiya Bykova, MD1*, Irina Nemchenko, MD, PhD1*, Olga Pospelova, MD1*, Margarita Gurianova, MD1*, Nikolay Tsyba, MD, PhD1*, Tatiana I. Ionova, Prof.2 and Anna G. Turkina, Prof., MD1

1National Research Center for Hematology, Moscow, Russian Federation
2University Clinic, St. Petersburg State University and Multinational Center for Quality of Life Research, Saint-Petersburg, Russia

Massimo Breccia, MD1*, Michael J. Mauro, MD2, Elias Jabbour, MD3, Giuseppe Saglio, MD, PhD4, Antonio Jiménez-Velasco, MD5*, Philipp D le Coutre, MD6, Irene DeGutis, PharmD7*, Wasiulla Khan, PhD7*, Oumar Sy, PhD7*, Rene Swanink8* and Jorge E. Cortes, MD9

1Department of Translational and Precision Medicine, Sapienza University, Rome, Italy
2Memorial Sloan-Kettering Cancer Center, New York, NY
3The University of Texas MD Anderson Cancer Center, Houston, TX
4Dept of Clinical and Biological Sciences, University of Turin, Orbassano, Italy
5Hospital Universitario Carlos Haya, Malaga, Spain
6Charité Universitätsmedizin Berlin, Berlin, Germany
7Bristol-Myers Squibb Company, Princeton, NJ
8Bristol-Myers Squibb, Braine-l'Alleud, Belgium
9Georgia Cancer Center, Augusta University, Augusta, GA

Zafar Iqbal, MPhil, PhD1,2,3,4,5, Muhammad Absar, BSc, MSc, PhD6,7*, Abid Jamil, MD PhD8,9*, Tanveer Akhtar, Ph.D10*, Salman Basit, PhD11*, Sibtain Afzal12*, Khushnooda Ramzan13*, Kulsoom Qureshi14*, Muhammad Farooq Sabar, Ph.D15*, Muhammad Arshad16*, Aamer Aleem, MBBS, FRCP, FRCPath17*, Ullah Anhar12,18*, Zeenat Mirza, PhD19*, Sajjad Karim19*, Naila Batool Khalid20*, Mahmood Rasool21*, Muhammad Asif, PhD22*, Mujib Ullah, PhD23*, Ahmad M Khalid, PhD24*, Amer Mahmood, PhD25* and Nawaf Alanazi, MBBS FRCPC26,27*

1Cancer & Medical Genetics, CoAMS-A, King Saud Bin Abdulaziz University for Health Sciences & King Abdullah International Medical Research Centre (KAIMRC) / SSBMT, King Abdulaziz Medical City, National Guard Health Affairs, Al-Ahsa, Saudi Arabia
2Centre for Advanced Molecular Biology, University of the Punjab, Lahore, Pakistan
3Qarshi University, HOPES, Department of Biotechnology & Genomic Medicine, Lahore, Pakistan
4Univ. of The Punjab, Pakistan, Lahore, Pakistan
5Pakistan Society for Molecular and Clinical Hematology, Lahore, Pakistan
6Department of Pathology, King Abdulaziz Hospital, King Abdulaziz Medical City, National Guard Health Affairs, Al Ahsa, Saudi Arabia
7Hematology, Oncology and Pharmacogenetics Engineering Sciences (HOPES) Group, Department of Zoology, University of the Punjab, Lahore, Pakistan
8Hayatabad Medical Complex, Peshawar, Pakistan
9HMC Peshawar, Peshawar, Pakistan
10HOPES Group, Hematology, Oncology and Pharmacogenetic Engineering Sciences (HOPES) Group Pakistan & HOPES Centre, Department of Zoology, University of the Punjab, Lahore, Pakistan
11College of Medicine, Taiba University, Madinah, Saudi Arabia
12College of Medicine, King Saud University, Riyadh, Saudi Arabia
13King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia
14Medical Oncology Unit, HMC, Peshawar, Khyber Pakhtunkhwa, PAK
15Core Genomics Laboratories, Centre for Applied Molecular Biology (CAMB), University of the Punjab, Lahore, Pakistan., Lahore, Pakistan
16Department of Biological Sciences, International Islamic University, Islamabad, Pakistan
17Hematology/Oncology Division, Department of Medicine, College of Medicine & King Khalid University Hospital, King Saud University, Riyadh, Saudi Arabia
18Hematology, Oncology and Pharmacogenetic Engineering Sciences (HOPES) Group Pakistan & HOPES Centre, Department of Zoology, University of the Punjab, Lahore, Pakistan
19Faculty of Applied Medical Sciences & Centre of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah, Saudi Arabia
20IMBB, University of Lahore, Lahore, Pakistan
21Faculty of Applied Medical Sciences & CEGMR, King Abdulaziz University, Jeddah, Saudi Arabia
22Department of Biotechnology, Balochistan University of Information Technology, Engineering and Management Sciences, (BUITEMS), Quetta, Pakistan
23Interventional Regenerative Medicine and Imaging Laboratory, Department of Radiology, Stanford University School of Medicine, Stanford, CA
24Department of Biotechnology & Genomic Medicine, Qarshi University, Lahore, Pakistan
25College of Medicine & King Khalid University Hospital, King Saud University (CoM KSU), Riyadh, Saudi Arabia
26Division of Pediatric Hematology /Oncology, Department of Medicine, King Abdulaziz Hospital, National Guard Health Affairs, Al Ahsa, Saudi Arabia
27CAMS-A (College of Applied Medical Sciences Al AHSA) King Saud Bin Abdulaziz University of Health Sciences & King Abdulaziz Hospital, National Guard Health Affairs, Al Ahsa, Saudi Arabia

Jorge E. Cortes, MD1, Philipp D le Coutre, MD2, Carlo Gambacorti-Passerini, MD3, Henrik Hjorth-Hansen, MD4, Pia Raanani, MD5, Valentín Garcia-Gutiérrez, MD, PhD6, Vamsi Kota, MD1, Simon Purcell7*, Andrea Viqueira8*, Eric Leip9* and Tim H Brümmendorf, MD10

1Georgia Cancer Center Augusta University, Augusta, GA
2Charité – Universitätsmedizin Berlin, Berlin, Berlin, Germany
3Dept of Medicine and Surgery, University of Milano Bicocca, Monza, MB, Italy
4Norwegian University of Science and Technology, Trondhein, Norway
5Institute of Hematology, Davidoff Cancer Center, Rabin Medical Center, Petah Tikva, Israel
6Hematology, Hospital Universitario Ramón y Cajal, Madrid, Spain
7Pfizer Ltd, London, GBR
8Pfizer SLU, Madrid, Spain
9Pfizer Inc., Cambridge, MA
10Dept. of Hematology and Oncology, Center for Integrated Oncology (CIO), Uniklinik RWTH Aachen, Aachen, Germany

Mario Tiribelli, MD1*, Roberto Latagliata2*, Massimo Breccia, MD3*, Isabella Capodanno, MD4*, Maria Cristina Miggiano, MD5*, Francesco Cavazzini, MD6*, Sabrina Leonetti Crescenzi, MD7*, Sabina Russo, MD8*, Mario Annunziata, MD9*, Federica Sorà, MD10*, Massimiliano Bonifacio, MD11*, Giovanni Caocci, MD12, Giuseppina Loglisci, MD13*, Alessandro Maggi14*, Gianni Binotto, MD15*, Elena Crisà, MD16*, Alessandra Iurlo, MD, PhD17*, Anna Rita Scortechini, MD18*, Annapaola Leporace, MD19*, Rosaria Sancetta, MD20*, Pamela Murgano, MD21*, Concettina Ruggiero, MD22*, Giuseppe Saglio, MD, PhD23 and Giorgina Specchia, MD24

1Division of Hematology and BMT, Department of Medical Area, University of Udine, Udine, Italy
2Hematology Unit, Ospedale Belcolle, Viterbo, Italy
3Department of Cellular Biotechnologies and Hematology, Sapienza University, Rome, Italy
4Hematology Unit, Azienda Unità Sanitaria Locale - IRCCS, Reggio Emilia, Italy
5Hematology Department, San Bortolo Hospital, Azienda ULSS8 "Berica" di Vicenza, Vicenza, Italy
6Division of Hematology, Department of Medical Sciences, University of Ferrara, Azienda Ospedaliera-Universitaria, Arcispedale S. Anna, Ferrara, Italy
7Hematology Unit, San Giovanni Hospital, Rome, Italy
8Department of Hematology, University of Messina, Messina, Italy
9Hematology Unit, Cardarelli Hospital, Naples, Italy
10Istituto di Ematologia, Fondazione Policlinico Universitario A. Gemelli, Università Cattolica del Sacro Cuore, Rome, Italy
11Department of Medicine, Section of Hematology, University of Verona, Verona, Italy
12Hematology Unit, Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, ITA
13Hematology Unit, Vito Fazzi Hospital, Lecce, Italy
14Hematology, " Giuseppe Moscati" Hospital, Taranto, Italy
15Department of Medicine, Hematology and Clinical Immunology, Padua School of Medicine, Padua, Italy
16Division of Hematology, Department of Translational Medicine, Università del Piemonte Orientale Amedeo Avogadro, AOU Maggiore della Carità, Novara, Italy
17Hematology Division, Foundation IRCCS Ca' Granda - Ospedale Maggiore Policlinico, Milano, Italy
18Division of Hematology, Azienda Ospedaliero Universitaria Ospedali Riuniti Ancona, Ancona, Italy
19Hematology Unit, Azienda Ospedaliero Universitaria Sant' Andrea, Rome, Italy
20Hematology Unit, Ospedale dell'Angelo, Venizia-Mestre, Italy
21Division of Hematology, S. Elia Hospital, Caltanissetta, Italy
22Division of Hematology, S. Eugenio Hospital, Rome, Italy
23Dept of Clinical and Biological Sciences, University of Turin, Orbassano, Italy
24Hematology - Dept. of Emergency and Organ Transplantation, University of Bari, Bari, Italy

Ana Ines Varela, MD1*, Georgina Bendek, MD2*, Carolina Pavlovsky3*, Maria Josefina Freitas, MD4*, Veronica Ventriglia, MD5*, Alicia Enrico, MD6,7*, Maria Elisa Riva, MD8*, Mariel Ana Perez, MD9*, Romina Mariano, MD10*, Luis Beligoy, MD11*, Maria Pagani12*, Ricardo Khalil Tannuri3*, Irene Larripa, MD13*, Raquel Bengio, MD14*, Francisca Rojas15*, Dardo Riveros, MD16*, Mariana Raquel Debus, MD17*, Erica Franceschi, MD18*, Maria Victoria Osycka19*, Miguel A. Pavlovsky, MD3 and Beatriz Moiraghi, MD1*

1Hospital General De Agudos J.M. Ramos Mejia, Buenos Aires, Argentina
2Hospital Italiano de Buenos Aires, Buenos Aires, Argentina
3FUNDALEU, Buenos Aires, Argentina
4Hospital Posadas, Argentina, Buenos Aires, Argentina
5Hospital Posadas, Buenos Aires, Argentina
6Hospital Zonal de Agudos, La Plata, Argentina
7Hospital Italiano La Plata, La Plata, MS, Argentina
8Hospital Interzonal de Agudos General San Martín de La Plata, La Plata, Argentina
9HIGA Prof.Dr.R.Rossi. La Plata, Bs.A, La Plata, Argentina
10Hospital San Martin, Parana, Argentina
11Hospital J. C. Perrando, Chaco, Argentina
12Hospital Ramos Mejia, Buenos Aires, Argentina
13Academia Nacional de Medicina, Buenos Aires, Argentina
14Academia Nacional de Medicina, IIHEMA, Buenos Aires, Argentina
15HOSPITAL DE CLINICAS JSM, Buenos Aires, ARG
16Hospital Universitario Cemic, buenos aires, Argentina
17Fundaleu, Buenos Aires, Argentina
18Hospital Militar, Buenos Aires, Argentina
19Hospital Penna, Buenos Aires, Argentina

*signifies non-member of ASH